New study!

Description of the natural history of vasculopathies

Motivation

Vascular malformations or anomalies are alterations in the development of the vascular system that are usually part of a larger pathological entity known as a syndrome. Tissues such as skin and bone have a predisposition to excessive growth, generating injuries and tumours that are usually very evident. This extensive growth has a great impact on the quality of life of the affected people and their families.

The diseases included in this study are the following:

  • Capillary malformations
    • Sturge-Weber syndrome
    • Pigmentovascular phakomatosis
  • Venous malformations
  • Lymphatic malformations
  • Arteriovenous Malformations (AVMs):
    • Cobb syndrome
    • Parkes-Weber syndrome
    • Capillary malformation syndrome (CM-AVM)
  • PI3K-associated overgrowth syndromes:
    • Macrocephaly / megalencephaly capillary malformation syndrome
    • CLOVES syndrome
    • Proteus syndrome
    • Capillary malformation with overgrowth
    • PROS
Objectives

Data on quality of life in this group of patients is really scarce. For this reason, we are promoting this project with the aim of advancing research and knowledge on these pathologies.

Method

The information provided by these patients or their caregivers will allow us to analyse and evaluate the psychosocial impact and the impact on the quality of life of these diseases in pediatric patients. Nine validated scales will be used as an instrument to report on pediatric dermatology, effects on mobility, pain intensity and impact of environmental attitudes.

New study!

Impact of neuromuscular diseases on education and working opportunities of patients and carers

Motivation

During the last 10 years, there has been a growing interest in developing research related to neuromuscular diseases. There are therapies that have been tested in clinical trials and some of them are already available for patients in the United States and the European Union.

However, very little is known about the impact of neuromuscular diseases on the education and employment opportunities of both patients and their caregivers, and this can have a significant impact on their quality of life and their access to potential treatments in the future. 

The diseases included in this study are the following:

  • Muscular dystrophies (MD)
    • Myotonic dystrophy (MD1 and MD2)
    • Fascioscapulohumeral MD (FSHD)
    • Limb girdle MD (LGMD)
    • Congenital muscular distrophies
  • Amyotrophic Lateral Sclerosis (ALS)
  • Peripheral neuropathies
    • Charcot Marie Tooth (CMT)
    • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Congenital myasthenias
    • Myasthenia gravis
  • Congenital myopathies
Objectives

Information provided directly by patients and their caregivers will allow us to understand the impact of rare neuromuscular diseases on the employment opportunities and the education of these patients and their families.

Method
  • Questionnaires developed and designed by the John Walton Muscular Dystrophy Research Centre at Newcastle University (UK) and the World Duchenne Organization.
  • Analysis of the data to understand the impact of neuromuscular diseases on the education and employment opportunities of patients and their families.